| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Offsite Care Resources is a Sebastopol, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Interface People is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Society of Breast Disease is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Allied Healthcare International Inc. is a provider of flexible, or temporary, healthcare staffing to the healthcare industry in the United Kingdom. The Company provides personal or basic care and nursing services in the home, in nursing and care homes